Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?

Posted byManisha Chatterjee Leave a comment on Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?

Israel-based Teva Pharmaceutical (TEVA) is conducting trials regarding the use of opioids. But is it wise to bet on the stock now based on its sound fundamentals? Read on, let’s…

Leave a comment

Your email address will not be published. Required fields are marked *